Gene transfer to hepatocellular carcinoma: Transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors

Cancer Gene Therapy

Volumn 7, Issue 9, 2000, Pages 1286-1292

  Gerolami, René ^a,b   Uch, Rathviro ^a   Jordier, François ^a   Chapel, Sylvie ^a   Bagnis, Claude ^a   Bréchot, Christian ^c   Mannoni, Patrice ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c INSERM   (France)

Author keywords

Enhanced green fluorescent protein; Gene transfer; Hepatocarcinoma; Lentiviral vectors; Retroviral vectors

Indexed keywords

AZACITIDINE; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 6; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRINAE; LEUKEMIA; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; MURINAE; MURINE LEUKEMIA VIRUS;

EID: 0033775626     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700225     Document Type: Article

References (31)

1. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients
2. Molecular mechanisms of hepatitis B and C viruses related liver carcinogenesis
3. Hepatocellular carcinoma
4. Primary carcinoma of the liver: Diagnosis, prognosis and management
5. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis
6. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients
7. Treatment of small hepatocellular carcinoma
8. Liver resection for hepatocellular carcinoma in cirrhotic patients
9. Multimodality treatment of hepatocellular carcinoma in Hepatobiliary Specialty Center
10. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
11. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients
12. A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
13. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma
14. Cytosine deaminase/5-fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice
15. Retroviral delivery of DNA into the livers of transgenic mice bearing premalignant and malignant hepatocellular carcinomas
16. Retrovirus-mediated gene therapy for hepatocellular carcinoma: Selective and enhanced suicide gene expression regulated by human α-fetoprotein enhancer directly linked to its promoter
17. Integration of murine leukemia virus DNA depends on mitosis
18. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1-derived vector system
19. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
20. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
21. High-dose multidrug resistance in primary hematopoietic progenitor cells transduced with optimized retroviral vectors
22. High-titer retroviral vectors containing the enhanced green fluorescent protein gene for efficient expression in hematopoietic cells
23. Expression of a retrovirally transduced gene under control of an internal housekeeping gene promoter does not persist due to methylation and is restored partially by 5-azacytidine treatment
24. 5'-Azacytidine prevents transgene methylation in vivo
25. A labile repressor acts through the NFκB-like binding sites of the human urokinase gene
26. NF-κB-mediated regulation of urokinase gene expression by PMA and TNF-α in human A549 cells
27. Cytokines and the hepatic acute phase response
28. Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors
29. Enhancer stimulation unmasks latent gene transfer after adenovirus-mediated gene delivery into human vascular smooth muscle cells
30. Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: Involvement of NFκB
31. Costimulation of transduced T lymphocytes via T cell receptor-CD3 complex and CD28 leads to increased transcription of integrated retrovirus